Patent · US Active

Compounds and compositions for inhibition of FASN

US10399951B2 · kind B2 · utility

4Cited by

55References

27Claims

0Family size

Assignee

FORMA Therapeutics, Inc. · US

Inventors

Kenneth W. Bair · Chapel Hill, US
David R. Lancia, Jr. · Boston, US
Hongbin Li · Newtown, US
James Loch · Watertown, US
Wei Lu · Newton, US
Matthew W. Martin · Arlington, US
David S. Millan · Watertown, US
Shawn Schiller · Haverhill, US
Mark J. Tebbe · Hamburg, DE

Key dates

Filing date	Aug 31, 2018
Grant date	Sep 3, 2019
Priority date	—
Expiry date	Aug 31, 2038

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D513/04
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to compounds and compositions for inhibition of FASN, their synthesis, applications, and antidotes.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.